ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677945 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677945; 2) Community: the network communities that were significantly associated with the response to NSC 677945; 3) Molecule: the relationships between components within communities and NSC 677945; 4) MDR: the compounds that were significantly associated with the NSC 677945.

NSC Compound Enrichment Correlation
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0396077140933377 -0.02855447
NSC 269760 B8 0.0396077140933377 0.27819355
NSC 303861 L-Cysteine analog 0.0396077140933377 0.10614575
NSC 321491 Null 0.0396077140933377 -0.12922695
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0396077140933377 -0.026424288
NSC 45236 Null 0.0396077140933377 -0.11428118
NSC 640735 3-(4-Methoxy-2-methylphenyl)naphthol [2,1-c]furan-1(3H)-one 0.0396077140933377 0.30112446
NSC 642947 Methanone, [3-(dibromomethyl)-6-chloroquinolin-2-yl] phenyl- 0.0396077140933377 0.11340294
NSC 647763 Jasplakinolide epoxide C 0.0396077140933377 0.0093029533
NSC 660313 Null 0.0396077140933377 0.19225069
Total:71  Current:59    [First] [Prev] [Next] [Last]